Odyssey Thera logo — Pioneering cellular pharmacology to discover groundbreaking...

Odyssey Thera

Pioneering cellular pharmacology to discover groundbreaking cancer therapies.

Founded 2000 11-50 employees Venture round Total: $6.30M Biopharma, Biotechnology +2

General Information

Company Name Odyssey Thera
Founded Year 2000
Employees 11-50
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Odyssey Thera. To contact Odyssey Thera, visit odysseythera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Odyssey Thera compare?

A PDF of Odyssey Thera and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Odyssey Thera soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Odyssey Thera

Odyssey Thera is a biopharmaceutical company focused on utilizing cellular pharmacology strategies to identify groundbreaking therapies for cancer. Established in 2000, in San Ramon, California, the company has undergone significant growth, attracting a substantial $2.80M in Venture Round investment on 14 February 2013, from notable investors including Burrill & Company, HBM Partners, and Lonza. Specializing in Biopharma, Biotechnology, Health Care, and Pharmaceutical industries, Odyssey Thera, Inc. is committed to developing treatment therapies for cancer, demonstrating a strong potential for both social impact and investment returns.

Business keywords: biopharmaceutical company, cellular pharmacology, cancer therapies, drug discovery, oncology research, precision medicine, San Ramon, California, medical research, pharmaceutical development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.80M 3
Burrill & Company, HBM Partners +1
14 Feb 2013
Venture Round $3.50M -
17 Mar 2010

Odyssey Thera Alternatives & Competitors

View All Alternatives
Odyssey Thera vs

Overcoming Resistance In Cancer

Post-IPO Equity
119 employees
Biopharma, Biotechnology
Odyssey Thera vs

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post-IPO Equity
14 employees
Biopharma, Biotechnology
Odyssey Thera vs
GLG Pharma
GLG Pharma United States

Why Show the GSK Compound? Because the cancer cells become resistant. How? By STAT3! GLG's Compounds...

Venture round
3 employees
Biotechnology, Health Care

FAQ About Odyssey Thera

Pioneering cellular pharmacology to discover groundbreaking cancer therapies.
Odyssey Thera was founded in 2000.
Odyssey Thera operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on biopharmaceutical company, cellular pharmacology, cancer therapies and drug discovery.
Odyssey Thera has approximately 11-50 employees.
Odyssey Thera has completed 2 funding rounds, raising a total of $6.30M. The latest funding stage is Venture round.
Top alternatives and competitors to Odyssey Thera include ORIC Pharmaceuticals Inc., Prescient Therapeutics, GLG Pharma, Nitrase Therapeutics, Afferent Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Odyssey Thera and ORIC Pharmaceuticals Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Odyssey Thera, https://bouncewatch.com/company/odyssey-thera, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes